IARC Director Elisabete Weiderpass to Speak at The Last Mile UN Dialogue on Cancer and NCDs
Elisabete Weiderpass/iarc.who.int

IARC Director Elisabete Weiderpass to Speak at The Last Mile UN Dialogue on Cancer and NCDs

IARC – International Agency for Research on Cancer/World Health Organization shared a post by International Cancer Patient Coalition on LinkedIn, adding:

”IARC Director Dr Elisabete Weiderpass will speak during The Last Mile UN Dialogue on cancer and NCDs.

Join her and other renowned experts for the “Bridging the Cancer and NCD Innovation Gap with AI, Early Detection, and Equitable Access” event.

Sep 24 | 15:00–18:00 EST
United Nations Headquarters, New York
Register.”

Quoting International Cancer Patient Coalition‘s post:

”We are honored to welcome Dr Elisabete Weiderpass, Director of IARC – International Agency for Research on Cancer / World Health Organization, as a speaker at the upcoming United Nations dialogue: “The Last Mile: Bridging the Cancer & NCD Innovation Gap with AI, Early Detection, and Equitable Access”

September 24, 2025 | 15:00–18:00 EST
United Nations Headquarters, New York – Conference Room 5

Register here to attend.

Dr. Weiderpass is a leading cancer epidemiologist and global health expert, serving as IARC Director since 2019. With over 700 scientific publications, she has dedicated her career to advancing cancer prevention and public health policy, ensuring that evidence-based strategies shape national and international responses to the global cancer epidemic.

At The Last Mile, Dr. Weiderpass will join “Session I – Early Detection and Health Systems Innovation: From Pilots to People”, bringing her perspective on how research, innovation, and global collaboration can accelerate prevention and early detection, particularly in low- and middle-income countries.

Her leadership at IARC continues to ensure that the Agency remains the global reference point for evidence-based prevention strategies and a trusted partner to governments and international organizations worldwide.”

Elisabete Weiderpass

More Posts Featuring IARC on OncoDaily.